More Post from the Author
- Sabre Corporation Announces Pricing of Senior Secured Notes Offering
- First Horizon Named to Forbes America's Best Companies 2026 List
- Sidd Ahmed, CEO of VDart Group, Named Most Admired CEO 2025 by Atlanta Business Chronicle
- Schneider Electric, AVEVA and ETAP Join Alliance for OpenUSD to Advance Digital Twins and 3D Modeling for Industries
- AutoMobility LA 2025
AdventHealth Tampa is first in Tampa Bay to offer implantable chemotherapy pump for patients with metastatic colorectal cancer
Published on Wed 19 Mar 2025 9:40:06 UTC
Hepatic Artery Infusion therapy delivers treatment directly tometastatic tumors in the liver, while minimizing the potential for systemic side effects
TAMPA, Fla., March 18, 2025 /PRNewswire/ -- AdventHealth Tampa is the first in the Tampa Bay area to offer a powerful new pump-based treatment option for colorectal cancer that has spread to the liver and for a rare form of cancer that forms in bile ducts within the liver called intrahepatic cholangiocarcinoma.
Hepatic Artery Infusion (HAI) therapy uses a pump that is implanted just below the skin in a patient's abdominal wall to deliver medicine directly to the liver through the hepatic artery, maximizing drug delivery to the tumors without adding systemic side effects.
More Post from the Author
- Sabre Corporation Announces Pricing of Senior Secured Notes Offering
- First Horizon Named to Forbes America's Best Companies 2026 List
- Sidd Ahmed, CEO of VDart Group, Named Most Admired CEO 2025 by Atlanta Business Chronicle
- Schneider Electric, AVEVA and ETAP Join Alliance for OpenUSD to Advance Digital Twins and 3D Modeling for Industries
- AutoMobility LA 2025


